Global Prostate cancer Market Research Report- Forecast To 2027

Global Prostate cancer Market Research Report- Forecast To 2027

ID: MRFR/HC/1051-HCRR | July, 2017 | Region: Global | 90 pages | Half-Cooked Research Reports

Global Prostate cancer Information, by product type hormone therapy, targeted therapies, therapeutic vaccines and others),   end users (hospitals, clinics and others) - Forecast to 2027


 


Study Objectives of Prostate cancer Market:



  • To provide detailed analysis of the market structure along with forecast for the next 10 years of the various segments and sub-segments of the Prostate cancer market

  • To provide insights about factors affecting the market growth

  • To analyze the prostate cancer market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.

  • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.

  • To provide country level analysis of the market with respect to the current market size and future prospective

  • To provide country level analysis of the market for segments by type, by application, by end users and its sub-segments.

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global Prostate cancer market.


 


 Intended Audience:



  • Companies related to Prostate cancer

  • Government research Laboratories

  • Research and Development (R&D) Companies

  • Independent Research Laboratories

  • Market Research and Consulting Service Providers

  • Medical Research Laboratories


 


Market Synopsis of Prostate cancer market:


Market Scenario:


Prostate cancer is cancer which occurs in a man's prostate. It is a small walnut-shaped gland that produces the seminal fluid that nourishes and transports sperm. It is one of the most common types of cancer in men. This type of cancer usually grows slowly and initially remains confined to the prostate gland where it may not cause serious harm. Some types of prostate cancer grow slowly and may need minimal or no treatment, other types are aggressive and can spread quickly. This market needs novel drugs that will address the unmet needs low cost and improved survival time.  


Market for Prostate cancer is growing due to an increase in prostate cancer population. The global market for Prostate cancer is expected to reach US$ XX by the end of the forecasted period and is expected to grow at a CAGR of XX%



Segments:


Global Prostate cancer market has been segmented on the basis of product type; market is segmented into targeted therapies, therapeutic vaccines, hormone therapy and others. On the basis of end users; market is segmented into hospitals, clinics and others.



Regional Analysis of Prostate cancer Market:


Globally North America is the largest market for cervical dystonia. The North American market for Prostate cancer is expected to grow at a CAGR of XX% and is expected to reach at US$ XXX Million by the end of the forecasted period. This is increasing as there is continuous input for innovative drugs to cure the diseases.


Europe is expected to be the second-largest market for Prostate cancer which is expected to grow at a CAGR of XX%.


 


Key Players for Prostate cancer market:


Some of the key players in this market are: OncoGenex Pharmaceuticals Inc. (US), Bayer Pharma AG (Berlin), Progenics Pharmaceuticals, Inc. (US), TOLMAR Inc. (US), OncBioMune Pharmaceuticals Inc. (US), Endo Pharmaceuticals Inc., Tokai Pharmaceuticals, Inc. and others.


 


The report for Global Prostate Cancer Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions

1    INTRODUCTION    

      1.1    DEFINITION    

      1.2    SCOPE OF STUDY    

            1.2.1    RESEARCH OBJECTIVE    

            1.2.2    ASSUMPTIONS & LIMITATIONS    

                1.2.2.1    ASSUMPTIONS    

                1.2.2.2    LIMITATIONS    

      1.3    MARKET STRUCTURE:    

2    RESEARCH METHODOLOGY    

      2.1    RESEARCH PROCESS:    

      2.2    PRIMARY RESEARCH    

      2.3    SECONDARY RESEARCH:    

3    MARKET DYNAMICS    

      3.1    DRIVERS    

      3.2    RESTRAINTS        

      3.3    OPPORTUNITIES    

      3.4    MACROECONOMIC INDICATORS    

4    MARKET FACTOR ANALYSIS    

      4.1    PORTERS FIVE FORCES MODEL    

      4.2    BARGAINING POWER OF SUPPLIERS    

      4.3    BARGAINING POWER OF BUYERS    

      4.4    THREAT OF NEW ENTRANTS    

      4.5    THREAT OF SUBSTITUTES    

      4.6    INTENSITY OF RIVALRY    

5.    GLOBAL PROSTATE CANCER MARKET, BY TREATMENT

      5.1    CHEMOTHERAPY

            5.1.1    ANTIMETABOLITES

            5.1.2    ANTHRACYCLINES

            5.1.3    TAXANES

            5.1.4    ALKYLATING AGENTS.

      5.2    SURGERY & RADIATION THERAPY

      5.3    TARGETED THERAPY

            5.3.1    TYROSINE KINASE INHIBITORS

            5.3.2    MONOCLONAL ANTIBODIES

      5.4    BIOLOGIC THERAPY

      5.5    HORMONE THERAPY

            5.5.1    ESTROGEN-RECEPTOR MODULATORS (SERMS)

            5.5.2    AROMATASE INHIBITORS

            5.5.3    OTHERS

      5.6    VACCINES

      5.7    OTHER

6.    GLOBAL PROSTATE CANCER MARKET, BY END USERS

      6.1    HOSPITALS

      6.2    CLINICS

      6.3    PHARMACIES

      6.4    OTHER

7.     GLOBAL PROSTATE CANCER MARKET, BY REGION

      7.1    INTRODUCTION

      7.2    AMERICA

            7.2.1    NORTH AMERICA

                7.2.1.1  US

                7.2.1.2  CANADA

            7.2.2    SOUTH AMERICA

      7.3    EUROPE

            7.3.1    WESTERN EUROPE

                7.3.1.1  GERMANY

                7.3.1.2  FRANCE

                7.3.1.3 I TALY

                7.3.1.3  SPAIN

                7.3.1.5  UK

                7.3.1.6  REST OF WESTERN EUROPE

            7.3.2    EASTERN EUROPE

      7.4    ASIA-PACIFIC

            7.4.1    JAPAN

            7.4.2    CHINA

            7.4.3    INDIA

            7.4.4    AUSTRALIA

            7.4.5    REPUBLIC OF KOREA

            7.4.6    REST OF ASIA-PACIFIC

      7.5    MIDDLE EAST & AFRICA

            7.5.1    UNITED ARAB EMIRATES

            7.5.2     SAUDI ARABIA

            7.5.3    OMAN

            7.5.4    KUWAIT

            7.5.5    QATAR

            7.5.6    REST OF MIDDLE EAST & AFRICA

8.    COMPETITIVE LANDSCAPE    

      8.1    MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS    

            8.1.1    STRATEGIC PARTNERSHIP    

            8.1.2    MERGER & ACQUISITION    

9    COMPANY PROFILE    

      9.1    ONCOGENEX PHARMACEUTICALS INC.

            9.1.1    OVERVIEW    

            9.1.2    PRODUCT OVERVIEW    

            9.1.3    FINANCIALS    

            9.1.4    KEY DEVELOPMENTS    

      9.2    BAYER PHARMA AG.

            9.2.1    OVERVIEW    

            9.2.2    PRODUCT OVERVIEW    

            9.2.3    FINANCIALS    

            9.2.4    KEY DEVELOPMENTS    

      9.3    PROGENICS PHARMACEUTICALS, INC..

            9.3.1    OVERVIEW

            9.3.2    PRODUCT OVERVIEW    

            9.3.3    FINANCIALS

            9.3.4    KEY DEVELOPMENT    

      9.4    TOLMAR INC.

            9.4.1    OVERVIEW

            9.4.2    PRODUCT OVERVIEW

            9.4.3    FINANCIALS

            9.4.4    KEY DEVELOPMENTS    

      9.5    ONCBIOMUNE PHARMACEUTICALS INC.

            9.5.1    OVERVIEW

            9.5.2    PRODUCT OVERVIEW    

            9.5.3    FINANCIALS    

            9.5.4    KEY DEVELOPMENTS    

      9.6    ENDO PHARMACEUTICALS INC

            9.6.1    OVERVIEW

            9.6.2    PRODUCT OVERVIEW    

            9.6.3    FINANCIALS    

            9.6.4    KEY DEVELOPMENTS    

      9.7    NOVARTIS

            9.7.1    OVERVIEW

            9.7.2    PRODUCT OVERVIEW    

            9.7.3    FINANCIALS    

            9.7.4    KEY DEVELOPMENTS    

      9.8    TOKAI PHARMACEUTICALS, INC

            9.8.1    OVERVIEW

            9.8.2    PRODUCT OVERVIEW    

            9.8.3    FINANCIALS    

            9.8.4    KEY DEVELOPMENTS    

      9.9    OTHERS

10         CONCLUSION

      10.1      KEY FINDINGS

            10.1.1   FROM CEO’S VIEWPOINT

            10.1.2   UNMET NEEDS OF THE MARKET

      10.2      KEY COMPANIES TO WATCH

      10.3      PREDICTION OF ONCOCARE INDUSTRY

11    APPENDIX